Novartis and Novo Nordisk see two cardiovascular drug candidates fail in trials
Detailed clinical trial results for cardiovascular disease drug candidates from Swiss multinational pharmaceutical company ‘Novartis’ and Danish pharmaceutical…
Browsing Tag